MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-08-0013612
Connectlife Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.28 Cr
▼ 22% YoY
Net profit · FY 2024
₹15.38 Lakh
Net margin 3.6%
EBITDA · FY 2024
₹21.86 Lakh
EBITDA margin 5.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Connectlife Pharma Private Limited
Data last updated:
Connectlife Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC343132. Its GSTIN is 07AAHCC9138R1ZV (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amar Keshri and Kanhaiya Keshri (Director Appointed In Casual Vacancy).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 204A Second Floor, Hemkunt Chambers 89, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.28 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹15.38 Lakh (net margin 3.6%) and EBITDA of ₹21.86 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 110% over five years.
Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
Connectlife Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0013612). For more details, the company can be reached via its website connectlife.in.
Company details
CIN U74999DL2018PTC343132
Registration Number 343132
Incorporation Date 17 December 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Small
Udyam Registration UDYAM-DL-08-0013612
Recognitions & Rankings of Connectlife Pharma
Contact details
Connectlife Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is connectlife.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address204A Second Floor, Hemkunt Chambers 89, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Connectlife Pharma Private Limited, buy the company report.
Comprehensive company report
Connectlife Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Connectlife Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Connectlife Pharma Private Limited, buy the company report.
Financials of Connectlife Pharma Private Limited
FY 2024 filings availableConnectlife Pharma Private Limited reported revenue of ₹4.28 Cr (down 22% YoY) for FY 2024.
Revenue · FY 2024
₹4.28 Cr ▼ 22%
Net profit · FY 2024
₹15.38 Lakh margin 3.6%
EBITDA · FY 2024
₹21.86 Lakh margin 5.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 14%
5 years · compounded
▲ 110%
EBITDA CAGR growth
1 year
▲ 156%
3 years · compounded
▲ 35%
5 years · compounded
▲ 63%
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 110%. EBITDA rose 156% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Connectlife Pharma Private Limited, buy the company report.
Board of directors of Connectlife Pharma Private Limited
Connectlife Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amar Keshri | Director | 17 Dec 2018 | 7 Years 10 Months | Current |
| Kanhaiya Keshri | Director Appointed In Casual Vacancy | 22 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Connectlife Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dhananjay Trexim Pvt Ltd | ₹4.29 Cr (FY 2025) | -21.0% | Kanpur, Uttar Pradesh, India | |||
| Connectlife Pharma Private Limitedthis company | ₹4.28 Cr (FY 2024) | ₹15.38 Lakh | 3.6% | -22.0% | New Delhi, Delhi, India | |
| Midway Pharmaceuticals Private Limited | ₹4.28 Cr (FY 2023) | 87.0% | Delhi, India | |||
| Bioves Pharmaceutical Private Limited | ₹4.28 Cr (FY 2025) | 10.0% | Hyderabad, Telangana, India | |||
| Remedial Healthcare India Private Limited | ₹4.27 Cr (FY 2024) | 16826133.0% | Ambala, Haryana, India |
To see the full peer comparison of Connectlife Pharma Private Limited, buy the company report.
Auditor
Connectlife Pharma Private Limited is audited by KAPOOR S & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAPOOR S & ASSOCIATES | FY 2023 | 037137N |
Shareholding
The shareholding of Connectlife Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Connectlife Pharma Private Limited, buy the company report.
Legal cases
Connectlife Pharma Private Limited has 2 court cases on record: 1 filed by Connectlife Pharma, 1 filed against it. All cases are disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Glaxo Group Limited | Disposed |
| District court, South East, Delhi | Civil suit | Filed by the company against Shri Balaji Industries Solution | Disposed |
To see the full case history of Connectlife Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Connectlife Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Connectlife Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCC9138R1ZV | Delhi | Active | 25 Jan 2019 |
To see the full GST registrations and return filing status of Connectlife Pharma Private Limited, buy the company report.
Recent activity
Connectlife Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Kanhaiya Keshri was appointed as Director Appointed In Casual Vacancy on 22 Mar 2019.
AGM
Connectlife Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Connectlife Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Kanhaiya Keshri was appointed as Director Appointed In Casual Vacancy.
Ceased
Manju Devi ceased to be Director.
Appointed
Amar Keshri was appointed as Director.
Incorporation
17 Dec 2018
Connectlife Pharma Private Limited was registered on 17 Dec 2018 with Roc Delhi & aged 7 years 10 months as per MCA records.
Frequently asked questions
Connectlife Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 December 2018 (8+ years old) and is registered under CIN U74999DL2018PTC343132.
Connectlife Pharma has 2 current directors:
- Amar Keshri - Director
- Kanhaiya Keshri - Director Appointed In Casual Vacancy
The latest financial statements of Connectlife Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Connectlife Pharma is 07AAHCC9138R1ZV, registered in Delhi.
The CIN (Corporate Identification Number) of Connectlife Pharma is U74999DL2018PTC343132. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Connectlife Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Connectlife Pharma was incorporated on 17 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Connectlife Pharma by revenue are Dhananjay Trexim Pvt Ltd, Midway Pharmaceuticals Private Limited, Bioves Pharmaceutical Private Limited, Remedial Healthcare India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Kanhaiya Keshri was appointed as Director Appointed In Casual Vacancy on 22 Mar 2019. Manju Devi ceased to be Director on 22 Mar 2019. Amar Keshri was appointed as Director on 17 Dec 2018.
Yes, Connectlife Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0013612).
Connectlife Pharma can be reached through the website connectlife.in. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages